Navigation Links
Lorus Advances Clinical Development of GTI-2040 Combined with Ara-C in Acute Myeloid Leukemia
Date:8/29/2007

strong antitumor and antimetastatic activity in a variety of tumor types in both in vivo and in vitro models and is under study in a multiple Phase I/II clinical program. R2 has been described as a malignant determinant that is elevated in a wide range of tumors, which can cooperate with a variety of cellular cancer causing genes known as oncogenes to enhance tumor growth and metastatic potential.

About Lorus

Lorus is a biopharmaceutical company focused on the research and development of novel therapeutics in cancer. Lorus' goal is to capitalize on its research, preclinical, clinical and regulatory expertise by developing new drug candidates that can be used, either alone, or in combination with other drugs, to successfully manage cancer. Through its own discovery efforts and an acquisition and in-licensing program, Lorus is building a portfolio of promising anticancer drugs. Lorus Therapeutics Inc. is listed on the Toronto Stock Exchange under the symbol LOR, and on the American Stock Exchange under the symbol LRP.

Forward-Looking Statements

This press release may contain forward-looking statements within the meaning of Canadian and U.S. securities laws. Such statements include, but are not limited to, statements relating to: our research program plans, our plans to conduct clinical trials, the successful and timely completion of clinical studies and the regulatory approval process, our ability to fund future research, our plans to obtain partners to assist in the further development of our product candidates, the establishment of corporate alliances, the Company's plans, objectives, expectations and intentions and other statements including words such as "continue", "believe", "plan", "expect", "intend", "will", "should", "may", and other similar expressions. Such statements reflect our current views with respect to future events and are subject to risks and uncertainties and are necessarily based upon a number of estimates and assumptions
'/>"/>

SOURCE Lorus Therapeutics Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. The Affymetrix GeneChip Scanner 3000 New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range
2. Quintessence Biosciences advances cancer drug
3. Healthcare slow to adopt genetic advances
4. Wireless advances in Madison, heats up in Waukesha
5. GE Healthcares CT Scanner advances coronary imaging
6. Cancer treatment advances as trials show no harm to mice
7. New CT scanner by GE Healthcare advances imaging technology
8. Small wonders: Intersection of biotech and nanotech will produce big advances
9. Standards Needed for Advances in Healthcare Technology
10. BioRobot MDx standardize your automated protocols in clinical laboratories
11. What patients want: A story of choice, clinical trials & evidence-based medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... York, NY (PRWEB) May 22, 2013 Mold ... Cleaning Products said that there is a way to cut ... it included on its latest post the details of a ... too much money. , Mold could be prevented, My Cleaning ... measures, the company stated that a mold remediation must then ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 Envera announced ... Fermentation Manager. Mr. McErlean has an extensive background ... leadership positions throughout his career. , Mike ... very pleased to have Mike join our team”. “Mike’s ... large scale fermentation and downstream processing equipment”, ...
(Date:5/22/2013)... 2013  Moderna Therapeutics, the pioneering company developing messenger ... the in vivo production of therapeutic proteins, ... will join Moderna in early July as its first ... proven leader in the design and implementation of information ... to translation, clinical operations and commercial preparedness. John has ...
(Date:5/21/2013)... NEW YORK , May 21, 2013  The Lindsley ... announced today that it is a Grand Challenges Explorations ... Melinda Gates Foundation .  Dr. Sara Lustigman ... an innovative global health and development research project, titled ... worms.  These worms are needed to screen drugs to ...
Breaking Biology Technology:How to Kill Mold While Saving Thousands of Dollars on Mold Remediation Projects Explained by My Cleaning Products 2Envera Appoints Michael McErlean Fermentation Manager 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 2Industry Leader John Reynders Joins Moderna Therapeutics as Chief Information Officer 3New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 3
... Pharmaceuticals, Inc. (Nasdaq: ANTH ), a ... associated with abnormal auto-immune responses and inflammation, today ... Officer, will present at Citi,s 2011 Global Health ... March 1, 2011, at approximately 1:30 pm Eastern ...
... revenues totaled 153.5 million euro in 2010 (approximately 211.4 ... million euro, or approximately 169.9 million USD). This performance ... Yondelis® sales. Net sales in the Biopharmaceutical ... USD) in 2010 (51.1 million euro, or approximately 70.3 ...
... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that a study ... Pathology demonstrated the ability of the ... of the highest risk HPV genotypes causing 70 percent of cervical ... study, which involved more than 47,000 women, validates the cobas ...
Cached Biology Technology:74 Percent EBITDA Improvement at Zeltia Group in 2010 2Pivotal Study Validates Roche's cobas® HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical Cancer 2Pivotal Study Validates Roche's cobas® HPV Test with HPV-16 and 18 Genotyping for Identifying Women at Highest Risk for Cervical Cancer 3
(Date:5/21/2013)... Cancers of all types become most deadly when they ... has reached this stage, it becomes very difficult for ... can develop. Now, researchers at the University of Missouri ... target lymphoma tumor cells wherever they may be in ... in the MU College of Veterinary Medicine, says being ...
(Date:5/21/2013)... Chemical Society (ACS), the world,s largest scientific society, ... Meeting & Exposition, September 8-12, 2013, in Indianapolis, ... Convention Center and at area hotels. , With ... span science,s horizons from astronomy to zoology ... online journalists a rich assortment of spot news ...
(Date:5/21/2013)... modifications, which alter the way genes function without ... detected in the blood of pregnant women during ... foretell depression in the weeks after giving birth, ... debilitating. , The findings of the small study ... the journal Molecular Psychiatry . , "Postpartum ...
Breaking Biology News(10 mins):MU researchers develop radioactive nanoparticles that target cancer cells 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 2Genetic predictors of postpartum depression uncovered by Hopkins researchers 3
... has captured another image of Iceland,s Eyjafjallajkull volcano ash ... ash into the air and the ash clouds are ... Terra satellite flew over the volcano on April 16 ... Resolution Imaging Spectroradiometer, or MODIS instrument aboard Terra captured ...
... have found a way to determine which somatic cells -- ... a primordial, embryonic-like state are the most viable for therapeutic ... the Journal of Biological Chemistry, two collaborating teams ... a marker they found in induced-pluripotent stem cells, or iPS ...
... Vienna, Austria, Friday 16 April 2010: Results from ... CongressTM 2010 press conference will help inform clinical practice ... alcoholic hepatitis. The first study demonstrated the ... from severe alcoholic hepatitis (SAH) earlier than the recommended ...
Cached Biology News:Chinese scientists discover marker indicating the developmental potential of stem cells 2New insights into treatment options for patients suffering from severe alcoholic hepatitis 2
... a high performance spectral scanning multimode ... With the advanced SkanIt Software it ... drug discovery assay development. Varioskan provides ... time-resolved fluorescence and photometric assays and ...
Strip Removal Tool 25/Box...
Oven mesh sheets, large, 23 x 23cm, pack of 5...
... Protein Phosphatase ( l-PPase) ... phosphatase with activity towards ... tyrosine residues. It is ... of the ORF221 open ...
Biology Products: